WHO vs. FDA: How The Biologic Naming Plans Stack Up

Side-by-side chart compares World Health Organization's initial published proposal with the final version and FDA's August 2015 draft guidance on nonproprietary naming of biologic products.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet